SCHEMBL19632865

SCHEMBL19632865

COc1ccc(C)cc1OCC(=O)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.57
LMNA P02545 4/20 0.55
TDP1 Q9NUW8 3/20 0.55
MAPK1 P28482 2/20 0.55
NPC1 O15118 3/20 0.53
RAB9A P51151 2/20 0.53
CTNNB1 P35222 2/20 0.52
WNT3A P56704 2/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
MAPT P10636 3/20 0.52
NPSR1 Q6W5P4 2/20 0.52
SMN1; SMN2 Q16637 3/20 0.51
POLB P06746 1/20 0.51
PTGDR2 Q9Y5Y4 1/20 0.50
HTT P42858 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27095797 0.87 L3MBTL1 (0.56) L3MBTL1LMNATDP1MAPK1NPC1
SCHEMBL9371798 0.85 L3MBTL1 (0.63) L3MBTL1LMNATDP1MAPK1NPC1
SCHEMBL13950675 0.85 LMNA (0.57) L3MBTL1LMNATDP1MAPK1NPC1
SCHEMBL9787268 0.84 POLB (0.71) L3MBTL1LMNATDP1MAPK1NPC1
SCHEMBL29620410 0.84 POLB (0.71) L3MBTL1LMNATDP1MAPK1NPC1
SCHEMBL5722802 0.84 PTGDR2 (0.53) L3MBTL1LMNATDP1MAPK1NPC1
SCHEMBL29115858 0.84 CTNNB1 (0.66) L3MBTL1TDP1MAPK1NPC1RAB9A
SCHEMBL30697348 0.84 CTNNB1 (0.66) L3MBTL1TDP1MAPK1NPC1RAB9A
SCHEMBL6583892 0.83 NPC1 (0.53) L3MBTL1LMNATDP1MAPK1NPC1
SCHEMBL17269686 0.83 POLB (0.64) L3MBTL1TDP1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10287226-B2 Mild catalytic reduction of C—O bonds and C═O bonds using a recyclable catalyst system ORGANOFUEL SWEDEN AB (SE) 2019-05-14 US disclosed
US-20170334819-A1 A MILD CATALYTIC REDUCTION OF C-O BONDS AND C=O BONDS USING A RECYCLABLE CATALYST SYSTEM ORGANOFUEL SWEDEN AB (SE) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334819-A1 A MILD CATALYTIC REDUCTION OF C-O BONDS AND C=O BONDS USING A RECYCLABLE CATALYST SYSTEM CBR1, ADH1C, AOC2 L3MBTL1 565/4885LMNA 1038/4885TDP1 2963/4885
US-10287226-B2 Mild catalytic reduction of C—O bonds and C═O bonds using a recyclable catalyst system CBR1, ADH1C, CBR3 L3MBTL1 575/4885LMNA 912/4885TDP1 2912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.